Healthcare provider profile · identity verified

Virgilio Sanchez, MD

Family Practice · MIAMI, FL · NPI 1124065693

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	594	185
Atorvastatin Calcium	Atorvastatin Calcium	515	164
Amlodipine Besylate	Amlodipine Besylate	491	136
Levothyroxine Sodium	Levothyroxine Sodium	439	133
Alprazolam	Alprazolam	427	68
Metformin Hcl	Metformin Hcl	322	105
Gabapentin	Gabapentin	310	76
Omeprazole	Omeprazole	300	86
Lisinopril	Lisinopril	290	89
Eliquis	Apixaban	277	57
Latanoprost	Latanoprost	240	44
Famotidine	Famotidine	239	66
Temazepam	Temazepam	233	31
Albuterol Sulfate Hfa	Albuterol Sulfate	220	44
Pantoprazole Sodium	Pantoprazole Sodium	212	61
Metoprolol Succinate	Metoprolol Succinate	208	66
Hydrochlorothiazide	Hydrochlorothiazide	202	56
Tamsulosin Hcl	Tamsulosin Hcl	178	51
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	175	57
Carvedilol	Carvedilol	171	44
Diclofenac Sodium	Diclofenac Sodium	156	62
Clonazepam	Clonazepam	153	28
Furosemide	Furosemide	134	38
Rosuvastatin Calcium	Rosuvastatin Calcium	132	44
Metoprolol Tartrate	Metoprolol Tartrate	126	34
Alcohol Prep Pads	Alcohol Antiseptic Pads	121	37
Ammonium Lactate	Ammonium Lactate	120	37
Escitalopram Oxalate	Escitalopram Oxalate	115	27
Atenolol	Atenolol	100	27
Fluticasone Propionate	Fluticasone Propionate	97	28
Donepezil Hcl	Donepezil Hcl	92	32
Clopidogrel	Clopidogrel Bisulfate	91	27
Trazodone Hcl	Trazodone Hcl	90	24
Ketoconazole	Ketoconazole	88	19
Simvastatin	Simvastatin	88	33
Januvia	Sitagliptin Phosphate	87	17
Montelukast Sodium	Montelukast Sodium	80	28
Metformin Hcl Er	Metformin Hcl	79	29
Nifedipine Er	Nifedipine	78	20
Finasteride	Finasteride	76	14
Memantine Hcl	Memantine Hcl	76	20
Potassium Chloride	Potassium Chloride	76	21
Xarelto	Rivaroxaban	66	11
Lorazepam	Lorazepam	65	12
Sildenafil Citrate	Sildenafil Citrate	64	16
Tramadol Hcl	Tramadol Hcl	63	15
Citalopram Hbr	Citalopram Hydrobromide	62	16
Glimepiride	Glimepiride	62	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	18
Triamcinolone Acetonide	Triamcinolone Acetonide	60	26
Azithromycin	Azithromycin	57	44
Paroxetine Hcl	Paroxetine Hcl	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	55	suppressed
Ciclopirox	Ciclopirox	54	15
Spironolactone	Spironolactone	54	suppressed
Allopurinol	Allopurinol	53	15
Enalapril Maleate	Enalapril Maleate	52	13
Pioglitazone Hcl	Pioglitazone Hcl	51	16
Entresto	Sacubitril/Valsartan	48	suppressed
Mupirocin	Mupirocin	48	20
Buspirone Hcl	Buspirone Hcl	47	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	46	suppressed
Glipizide	Glipizide	46	12
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Pregabalin	Pregabalin	43	suppressed
Symbicort	Budesonide/Formoterol Fumarate	43	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	11
Hydrocortisone	Hydrocortisone	40	12
Tradjenta	Linagliptin	40	suppressed
Combigan	Brimonidine Tartrate/Timolol	38	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Prednisone	Prednisone	38	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Lumigan	Bimatoprost	35	suppressed
Lactulose	Lactulose	34	suppressed
Meloxicam	Meloxicam	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	32	12
Clonidine Hcl	Clonidine Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Timolol Maleate	Timolol Maleate	30	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	30	suppressed
Clobetasol Propionate	Clobetasol Propionate	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Sertraline Hcl	Sertraline Hcl	28	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Ssd	Silver Sulfadiazine	25	11
Valsartan	Valsartan	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	16
Labetalol Hcl	Labetalol Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nystatin	Nystatin	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	20	suppressed
Folic Acid	Folic Acid	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	18	17
Bumetanide	Bumetanide	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Bicalutamide	Bicalutamide	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Anastrozole	Anastrozole	16	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Galantamine Er	Galantamine Hbr	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Victoza 3-Pak	Liraglutide	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Ibuprofen	Ibuprofen	15	11
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Verapamil Hcl	Verapamil Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Calcium Acetate	Calcium Acetate	14	suppressed
Digoxin	Digoxin	14	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Valproic Acid	Valproic Acid	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Baclofen	Baclofen	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acarbose	Acarbose	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Letrozole	Letrozole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Primidone	Primidone	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error